David-Alexandre C. Gros
2021 - Tokai Pharmaceuticals
In 2021, David-Alexandre C. Gros earned a total compensation of $604.1K as Chief Executive Officer at Tokai Pharmaceuticals, a 92% decrease compared to previous year.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Salary | $503,654 |
| Other | $450 |
| Total | $604,104 |
Gros received $503.7K in salary, accounting for 83% of the total pay in 2021.
Gros also received $100K in bonus and $450 in other compensation.
Rankings
In 2021, David-Alexandre C. Gros' compensation ranked 10,297th out of 12,415 executives tracked by ExecPay. In other words, Gros earned more than 17.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,297 out of 12,415 | 17th |
Division Manufacturing | 4,561 out of 5,501 | 17th |
Major group Chemicals And Allied Products | 2,040 out of 2,374 | 14th |
Industry group Drugs | 1,809 out of 2,095 | 14th |
Industry Pharmaceutical Preparations | 1,341 out of 1,542 | 13th |
Source: SEC filing on April 28, 2022.
Gros' colleagues
We found two more compensation records of executives who worked with David-Alexandre C. Gros at Tokai Pharmaceuticals in 2021.